UPDATE: Danaher Q2 Revenues Up 4 Percent, Beating Analyst Estimates | GenomeWeb

The story has been updated with comments from Danaher's second-quarter earnings conference call.

NEW YORK (GenomeWeb News) – Danaher today reported a 4 percent year-over-year increase in revenues for the second quarter, while Life Sciences and Diagnostics revenues rose nearly 6 percent.

For the three months ended June 28, the Washington, DC-based conglomerate pulled in total revenues of $4.74 billion, up from $4.55 billion, topping the consensus Wall Street estimate of $4.72 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.